Patents by Inventor Christopher Nye

Christopher Nye has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Therapeutic editing
    Patent number: 11827880
    Abstract: Disclosed herein are compositions that comprise engineered polynucleotides, pharmaceutical compositions comprising the same, methods of making the same, and methods of treatment comprising the compositions that comprise the engineered polynucleotides.
    Type: Grant
    Filed: December 1, 2020
    Date of Patent: November 28, 2023
    Assignee: Shape Therapeutics Inc.
    Inventors: David Huss, Prashant Mali, Anupama Lakshmanan, Christopher Nye, Yiannis Savva, Liana Stein, Richard Sullivan, Rafael Ponce, Susan Byrne
  • Therapeutic Editing
    Publication number: 20230044119
    Abstract: Disclosed herein are compositions that comprise engineered polynucleotides, pharmaceutical compositions comprising the same, methods of making the same, and methods of treatment comprising the compositions that comprise the engineered polynucleotides.
    Type: Application
    Filed: December 1, 2020
    Publication date: February 9, 2023
    Inventors: David HUSS, Prashant MALI, Anupama LAKSHMANAN, Christopher NYE, Yiannis SAVVA, Liana STEIN, Richard SULLIVAN, Rafael PONCE, Susan BYRNE
  • RNA Modification to Engineer Cas9 Activity
    Publication number: 20170114334
    Abstract: The disclosure provides for compositions, methods and kits, for reducing off-target effects of genome engineering.
    Type: Application
    Filed: December 26, 2016
    Publication date: April 27, 2017
    Inventors: Andrew Paul May, Paul Daniel Donohoue, Christopher Nye, Euan Slorach, Rachel E. Haurwitz
  • RNA Modification to Engineer Cas9 Activity
    Publication number: 20150376587
    Abstract: The disclosure provides for compositions, methods and kits, for reducing off-target effects of genome engineering.
    Type: Application
    Filed: July 2, 2015
    Publication date: December 31, 2015
    Inventors: Andrew Paul May, Paul Donohoue, Christopher Nye, Euan Slorach, Rachel Haurwitz
  • RNA Modification to Engineer Cas9 Activity
    Publication number: 20150376586
    Abstract: The disclosure provides for compositions, methods and kits, for reducing off-target effects of genome engineering.
    Type: Application
    Filed: July 2, 2015
    Publication date: December 31, 2015
    Inventors: Andrew Paul May, Paul Donohoue, Christopher Nye, Euan Slorach, Rachel Haurwitz